A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation-Reference-Cited by-同舟云学术

A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation

Published:2017-03-23 Issue:4 Volume:23 Page:487-497
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Sood Siddharth¹²³,Haifer Craig¹,Yu Lijia³,Pavlovic Julie¹,Churilov Leonid⁴,Gow Paul J.¹,Jones Robert M.¹,Angus Peter W.¹,Visvanathan Kumar³,Testro Adam G.¹

Affiliation:

1. Liver Transplant Unit

2. Department of Gastroenterology and Hepatology, Royal Melbourne Hospital; University of Melbourne; Parkville Victoria Australia

3. Innate Immune Laboratory, St. Vincent's Hospital; University of Melbourne; Melbourne Victoria Australia

4. Florey Department of Neuroscience and Mental Health, Austin Health

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference26 articles.

1. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients;Venkataramanan;J Clin Pharmacol,2001

2. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool;Gebauer;Am J Transplant,2002

3. A novel biomarker of immune function and initial experience in a transplant population;Sood;Transplantation,2014

4. The international sepsis forum consensus conference on definitions of infection in the intensive care unit;Calandra;Crit Care Med,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights on the monitoring of solid-organ allografts based on immune cell signatures;Transplant Immunology;2022-02

2. Low Levels of Hepatocyte‐Specific Methylation in cfDNA are a Strong Negative Predictor for Acute T‐cell Mediated Rejection requiring Treatment following Liver Transplantation;Liver Transplantation;2021-12-16

3. Correlation between insulin-like growth factor 1 levels and tacrolimus dose in pediatric liver recipients;Russian Journal of Transplantology and Artificial Organs;2021-07-12

4. Evaluation of Quantiferon®‐Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients;Transplant Infectious Disease;2021-01-05

5. Donor-specific cell-free DNA as a biomarker in liver transplantation: A review;World Journal of Transplantation;2020-11-28